ATOSSA THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q4 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Atossa Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2012 to Q3 2024.
  • Atossa Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 126M shares, a 0.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 126M +497K +0.4% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 126M -27.8K -0.02% Aug 1, 2024 10-Q 2024-08-12
Q1 2024 125M -1.32M -1.04% Mar 15, 2024 10-K 2024-04-01
Q3 2023 125M -1.32M -1.04% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 126M -839K -0.66% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 127M 0 0% Mar 16, 2023 10-K 2023-03-22
Q3 2022 127M 0 0% Nov 4, 2022 10-Q 2022-11-07
Q2 2022 127M +854 +0% Aug 5, 2022 10-Q 2022-08-08
Q1 2022 127M +5.8M +4.8% May 6, 2022 10-Q 2022-05-09
Q3 2021 127M +116M +1107% Nov 11, 2021 10-Q 2021-11-15
Q2 2021 127M +116M +1118% Aug 6, 2021 10-Q 2021-08-13
Q1 2021 121M +112M +1223% Mar 24, 2021 10-K 2021-03-31
Q3 2020 10.5M +1.36M +14.9% Nov 9, 2020 10-Q 2020-11-13
Q2 2020 10.4M +1.27M +13.9% Aug 10, 2020 10-Q 2020-08-13
Q1 2020 9.13M +14.5K +0.16% Mar 24, 2020 10-K 2020-03-26
Q3 2019 9.13M +3.48M +61.7% Nov 11, 2019 10-Q 2019-11-13
Q2 2019 9.13M +4.06M +80.1% Aug 9, 2019 10-Q 2019-08-13
Q1 2019 9.12M -22.7M -71.4% Mar 25, 2019 10-K 2019-03-28
Q3 2018 5.65M -20.9M -78.7% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 5.07M -6.63M -56.7% Aug 10, 2018 10-Q/A 2018-11-13
Q1 2018 31.8M +28M +740% Feb 28, 2018 10-K 2018-03-08
Q3 2017 26.5M +22.7M +600% Nov 12, 2017 10-Q 2017-11-13
Q2 2017 11.7M -27.9M -70.4% Aug 14, 2017 10-Q 2017-08-14
Q1 2017 3.79M -35M -90.2% Mar 20, 2017 10-K/A 2017-03-21
Q3 2016 3.79M -26.7M -87.6% Nov 11, 2016 10-Q/A 2017-03-21
Q2 2016 39.6M +10.5M +36.2% Aug 12, 2016 10-Q/A 2017-03-21
Q1 2016 38.8M +13.4M +52.9% Mar 28, 2016 10-K 2016-03-30
Q3 2015 30.4M +5.88M +23.9% Nov 12, 2015 10-Q 2015-11-12
Q2 2015 29M +4.48M +18.2% Aug 6, 2015 10-Q 2015-08-06
Q1 2015 25.4M +968K +3.96% Mar 27, 2015 10-K 2015-03-30
Q3 2014 24.6M +6.54M +36.3% Nov 12, 2014 10-Q 2014-11-12
Q2 2014 24.6M +8.98M +57.7% Aug 12, 2014 10-Q 2014-08-12
Q1 2014 24.4M +10.3M +72.3% Mar 24, 2014 10-K 2014-03-27
Q3 2013 18M Nov 8, 2013 10-Q 2013-11-12
Q2 2013 15.6M Aug 9, 2013 10-Q 2013-08-14
Q1 2013 14.2M Mar 27, 2013 10-K 2013-03-28
Q4 2012 12.9M Dec 19, 2012 10-Q/A 2013-01-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.